pevonedistat
Showing 1 - 17 of 17
Myelofibroses Trial in Saint Louis (Pevonedistat, Ruxolitinib, Peripheral blood draw)
Terminated
- Myelofibroses
- Pevonedistat
- +3 more
-
Saint Louis, MissouriWashington University School of Medicine
Dec 16, 2021
NSCLC Trial in Ann Arbor (Pevonedistat, Docetaxel)
Terminated
- Non-small Cell Lung Cancer
- Pevonedistat
- Docetaxel
-
Ann Arbor, MichiganUniversity of Michigan Comprehensive Cancer Center
Dec 16, 2021
Locally Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in Houston
Active, not recruiting
- Locally Advanced Malignant Solid Neoplasm
- +2 more
- Pembrolizumab
- Pevonedistat
-
Houston, TexasM D Anderson Cancer Center
Jan 18, 2022
MDS Trial (Pevonedistat, Azacitidine)
No longer available
- Myelodysplastic Syndromes
- Pevonedistat
- Azacitidine
- (no location specified)
Sep 8, 2021
MDS (MDS) Trial (Pevonedistat, Decitabine, Cedazuridine)
Withdrawn
- Myelodysplastic Syndromes (MDS)
- Pevonedistat
- +2 more
- (no location specified)
Sep 23, 2021
Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Duarte (Decitabine,
Active, not recruiting
- Acute Myeloid Leukemia
- +5 more
- Decitabine
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 17, 2022
Acute Myelogenous Leukemia, AML, Advanced MDS Trial in Miami (Pevonedistat, Cytarabine)
Completed
- Acute Myelogenous Leukemia
- +3 more
- Pevonedistat
- Cytarabine
-
Miami, FloridaUniversity of Miami
Dec 7, 2021
Refractory Acute Lymphoblastic Leukemia, Relapsed Acute Lymphoblastic Leukemia Trial in Miami (Pevonedistat, Vincristine,
Active, not recruiting
- Refractory Acute Lymphoblastic Leukemia
- Relapsed Acute Lymphoblastic Leukemia
- Pevonedistat
- +7 more
-
Miami, FloridaUniversity of Miami
Nov 2, 2021
Mesothelioma Trial in United States (pevonedistat, Pemetrexed and cisplatin)
Active, not recruiting
- Mesothelioma
- pevonedistat
- Pemetrexed and cisplatin
-
Basking Ridge, New Jersey
- +7 more
Sep 10, 2021
Acute Myelogenous Leukemia Trial in Rochester, Milwaukee (Azacitidine, Venetoclax, Pevonedistat)
Active, not recruiting
- Acute Myelogenous Leukemia
- Azacitidine
- +2 more
-
Rochester, Minnesota
- +1 more
Sep 21, 2021
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia With Myelodysplasia-Related
Active, not recruiting
- Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
- +2 more
- Cytarabine
- +4 more
-
Tucson, Arizona
- +2 more
Aug 5, 2022
Advanced Solid Tumor Trial in United States (Pevonedistat, Docetaxel, Carboplatin)
Completed
- Advanced Solid Neoplasm
- Pevonedistat
- +3 more
-
Santa Monica, California
- +7 more
Jun 22, 2021
Acute Myeloid Leukemia in Remission, MDS, Minimal Residual Disease Trial in Germany (Pevonedistat, Azacitidine)
Active, not recruiting
- Acute Myeloid Leukemia in Remission
- +2 more
- Pevonedistat
- Azacitidine
-
Aachen, Germany
- +13 more
Jul 11, 2022
Acute Myeloid Leukemia (AML) Trial in Hershey (Pevonedistat, transplant, Azacitidine)
Terminated
- Acute Myeloid Leukemia (AML)
- Pevonedistat
- +2 more
-
Hershey, PennsylvaniaPenn State Hershey Medical Center: Penn State Cancer Institute
Nov 22, 2020
Advanced Solid Tumors, Tumors, Advanced Solid Trial in Budapest (Pevonedistat, [14C]-Pevonedistat, Docetaxel)
Completed
- Advanced Solid Tumors, Neoplasms, Advanced Solid
- Pevonedistat
- +4 more
-
Budapest, Hungary
- +1 more
Nov 4, 2019
Leukemia, Myeloid, Acute Trial in Portugal, Spain (Pevonedistat, Azacitidine)
Recruiting
- Leukemia, Myeloid, Acute
- Pevonedistat
- Azacitidine
-
Coimbra, Portugal
- +67 more
Jul 15, 2021
Myelodysplastic Syndrome, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Acute Trial in Worldwide (Azacitidine,
Active, not recruiting
- Myelodysplastic Syndrome
- +2 more
- Azacitidine
- Pevonedistat
-
Daphne, Alabama
- +241 more
Feb 18, 2022